Cargando…
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365083/ https://www.ncbi.nlm.nih.gov/pubmed/32682954 http://dx.doi.org/10.1016/j.nbd.2020.105010 |